Global Influenza Vaccine Market: Industry Analysis & Outlook (2017-2021)
Influenza, also known as flu, is a contagious disease which spreads from person to person very rapidly. When an infected person sneezes or coughs the virus spreads to those close by, affecting immuno-compromised patients the most. The influenza virus is broadly classified as influenza A, influenza B, and influenza C. The influenza vaccine come in both inactive and weakened viral forms.
The global influenza vaccine market is relatively untouched and has huge potential to treat any major outbreak. The influenza vaccine market in the US is the largest market globally because of its strong dynamics and a great scope of innovation in the region. The growth factors of the market include increase in incidence of H1N1 outbreaks, rising spending on public healthcare programs, growth of the market in emerging economies, escalating ageing population and increase in spending on medicines and healthcare expenditure.
The global influenza vaccine market is trending with development of new drugs, use of new technologies, rise in FDA approvals, and increase in efficiency rate of influenza vaccines, booming public private partnership and growing awareness. However, the market growth will be hindered by complex development and production process, unclear process for introduction of new vaccines and high R&D costs.
The report offers an in-depth analysis of the global influenza vaccine market along with regional insights. The top notch players in the market exhibit a very close competition. The report profiles Sanofi S.A, Novartis AG, AstraZeneca PLC and GlaxoSmithKline Plc.
The global influenza vaccine market is relatively untouched and has huge potential to treat any major outbreak. The influenza vaccine market in the US is the largest market globally because of its strong dynamics and a great scope of innovation in the region. The growth factors of the market include increase in incidence of H1N1 outbreaks, rising spending on public healthcare programs, growth of the market in emerging economies, escalating ageing population and increase in spending on medicines and healthcare expenditure.
The global influenza vaccine market is trending with development of new drugs, use of new technologies, rise in FDA approvals, and increase in efficiency rate of influenza vaccines, booming public private partnership and growing awareness. However, the market growth will be hindered by complex development and production process, unclear process for introduction of new vaccines and high R&D costs.
The report offers an in-depth analysis of the global influenza vaccine market along with regional insights. The top notch players in the market exhibit a very close competition. The report profiles Sanofi S.A, Novartis AG, AstraZeneca PLC and GlaxoSmithKline Plc.
1. MARKET OVERVIEW
1.1 Influenza
1.1.1 Types of Influenza
1.1.2 Symptoms
1.2 Influenza Vaccine
1.2.1 Types
1.2.2 Supply Chain of Influenza Vaccine
1.2.3 Side Effects
2. GLOBAL INFLUENZA VACCINE MARKET ANALYSIS
2.1 Global Influenza Vaccine Market by Value
2.2 Global Influenza Vaccine Market Forecast by Value
2.3 Global Influenza Vaccine Production Capacity by Indication
2.4 Global Influenza Vaccine Production Capacity
2.4.1 Global Pandemic Influenza Vaccine Production Capacity
2.4.2 Global Pandemic Influenza Vaccine Production Capacity Forecast
2.4.3 Global Seasonal Influenza Vaccine Production Capacity
2.4.4 Global Seasonal Influenza Vaccine Production Capacity Forecast
2.5 Global Influenza Vaccine Market by Region
3. REGIONAL INFLUENZA VACCINE MARKET ANALYSIS
3.1 The US
3.1.1 The US Influenza Vaccine Market by Value
3.1.2 The US Influenza Vaccine Market Forecast by Value
3.1.3 The US Influenza Vaccine Production Volume
3.1.4 The US Influenza Vaccine Production Volume Forecast
3.1.5 The US Influenza Vaccine Market Volume by Type
3.2 Japan
3.2.1 Japan’s Influenza Vaccine Market by Value
3.2.2 Japan’s Influenza Vaccine Market Forecast by Value
3.3 Germany
3.3.1 Germany’s Influenza Vaccine Market by Value
3.3.2 Germany’s Influenza Vaccine Market Forecast by Value
4. MARKET DYNAMICS
4.1 Key Trends & Developments
4.1.1 Increase in Development of New Drugs
4.1.2 Use of New Technology
4.1.3 Rise in FDA Approvals
4.1.4 Influenza Vaccine Effectiveness
4.1.5 Booming Public-Private Corporation
4.1.6 Public Awareness on Rise
4.2 Growth Drivers
4.2.1 Development of H1N1/H5N1 Vaccines
4.2.2 Rise of Retail Clinics
4.2.3 Rising Spending on Public Health Programs
4.2.4 Growing Influenza Vaccine Market in Emerging Economies
4.2.5 Increased Spending on Medicines
4.2.6 Increasing Global Healthcare Expenditure
4.2.7 Escalating Ageing Population
4.3 Challenges & Issues
4.3.1 Complex Development and Production Process
4.3.2 Unclear Process in Introducing New Vaccines
4.3.3 High R&D Costs
5. COMPETITIVE LANDSCAPE
5.1 Global Influenza Vaccine Market
5.1.1 Market Share Comparison
5.1.2 Competition by Drugs & Indication
5.1.3 Revenue Comparison
5.1.4 Market Cap Comparison
5.2 The US Influenza Vaccine Market
5.2.1 Production Volume Share
6. COMPANY PROFILES
6.1 Novartis AG
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Sanofi S.A
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 GlaxoSmithKline Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 AstraZeneca
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
1.1 Influenza
1.1.1 Types of Influenza
1.1.2 Symptoms
1.2 Influenza Vaccine
1.2.1 Types
1.2.2 Supply Chain of Influenza Vaccine
1.2.3 Side Effects
2. GLOBAL INFLUENZA VACCINE MARKET ANALYSIS
2.1 Global Influenza Vaccine Market by Value
2.2 Global Influenza Vaccine Market Forecast by Value
2.3 Global Influenza Vaccine Production Capacity by Indication
2.4 Global Influenza Vaccine Production Capacity
2.4.1 Global Pandemic Influenza Vaccine Production Capacity
2.4.2 Global Pandemic Influenza Vaccine Production Capacity Forecast
2.4.3 Global Seasonal Influenza Vaccine Production Capacity
2.4.4 Global Seasonal Influenza Vaccine Production Capacity Forecast
2.5 Global Influenza Vaccine Market by Region
3. REGIONAL INFLUENZA VACCINE MARKET ANALYSIS
3.1 The US
3.1.1 The US Influenza Vaccine Market by Value
3.1.2 The US Influenza Vaccine Market Forecast by Value
3.1.3 The US Influenza Vaccine Production Volume
3.1.4 The US Influenza Vaccine Production Volume Forecast
3.1.5 The US Influenza Vaccine Market Volume by Type
3.2 Japan
3.2.1 Japan’s Influenza Vaccine Market by Value
3.2.2 Japan’s Influenza Vaccine Market Forecast by Value
3.3 Germany
3.3.1 Germany’s Influenza Vaccine Market by Value
3.3.2 Germany’s Influenza Vaccine Market Forecast by Value
4. MARKET DYNAMICS
4.1 Key Trends & Developments
4.1.1 Increase in Development of New Drugs
4.1.2 Use of New Technology
4.1.3 Rise in FDA Approvals
4.1.4 Influenza Vaccine Effectiveness
4.1.5 Booming Public-Private Corporation
4.1.6 Public Awareness on Rise
4.2 Growth Drivers
4.2.1 Development of H1N1/H5N1 Vaccines
4.2.2 Rise of Retail Clinics
4.2.3 Rising Spending on Public Health Programs
4.2.4 Growing Influenza Vaccine Market in Emerging Economies
4.2.5 Increased Spending on Medicines
4.2.6 Increasing Global Healthcare Expenditure
4.2.7 Escalating Ageing Population
4.3 Challenges & Issues
4.3.1 Complex Development and Production Process
4.3.2 Unclear Process in Introducing New Vaccines
4.3.3 High R&D Costs
5. COMPETITIVE LANDSCAPE
5.1 Global Influenza Vaccine Market
5.1.1 Market Share Comparison
5.1.2 Competition by Drugs & Indication
5.1.3 Revenue Comparison
5.1.4 Market Cap Comparison
5.2 The US Influenza Vaccine Market
5.2.1 Production Volume Share
6. COMPANY PROFILES
6.1 Novartis AG
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Sanofi S.A
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 GlaxoSmithKline Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 AstraZeneca
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
LIST OF CHARTS
Types of Influenza
Symptoms of Influenza
Supply Chain of Influenza Vaccine
Global Influenza Vaccine Market by Value (2012-2016)
Global Influenza Vaccine Market Forecast by Value (2017-2021)
Global Influenza Vaccine Production Capacity by Indication (2016)
Global Pandemic Influenza Vaccine Production Capacity (2012-2016)
Global Pandemic Influenza Vaccine Production Capacity Forecast (2017-2021)
Global Seasonal Influenza Vaccine Production Capacity (2012-2016)
Global Seasonal Influenza Vaccine Production Capacity Forecast (2017-2021)
Global Influenza Vaccine Market by Region (2016)
The US Influenza Vaccine Market by Value (2012-2016)
The US Influenza Vaccine Market Forecast by Value (2017-2021)
The US Influenza Vaccine Production Volume (2012-2016)
The US Influenza Vaccine Production Volume Forecast (2017-2021)
The US Influenza Vaccine Market Volume by Type (2016)
Japan’s Influenza Vaccine Market by Value (2012-2016)
Japan’s Influenza Vaccine Market Forecast by Value (2017-2021)
Germany’s Influenza Vaccine Market by Value (2012-2016)
Germany’s Influenza Vaccine Market Forecast by Value (2017-2021)
Vaccine Effectiveness for Influenza Seasons (2005-2016)
Global Spending on Medicines (2010-2020E)
Total Spending on Medicines in the US (2012-2016)
Global Healthcare Expenditure (2012-2016)
Global Ageing Population of 60 Years or Older (2000-2030E)
Global Influenza Vaccine Market Share (2016)
Revenue Comparison by Key Players (2016)
Market Cap Comparison by Key Players (2016)
The US Influenza Vaccine Production Volume Share (2016)
Novartis Revenue Share by Segments (2015)
Novartis AG’s Revenue and Net Income (2012-2015)
Sanofi S.A Net Sales Share by Business Segments (2015)
Sanofi S.A Net Sales and Net Income (2012-2015)
GlaxoSmithKline Plc. Net Sales Share by Segments (2015)
GlaxoSmithKline Plc. Net Sales and Operating Profit (2012-2015)
AstraZeneca Revenue by Segment (2015)
AstraZeneca’s Revenue (2012-2015)
List of Tables
Difference between Influenza Types A, B and C Viruses
Influenza Vaccine Side Effects
Flu Vaccines Lots Released by the FDA (2016/2017)
H1N1/H5N1 Vaccine in Development (2015-2016)
Number of Retail Clinics in the US (2015)
Global Influenza Vaccine Market Competition by Drugs & Indication (2016)
Sanofi S.A Key Product Enhancement Strategies (2015)
GlaxoSmithKline Plc. Core R&D Expenditure Allocation (2015)
GSK Product Development Pipeline in Pharmaceutical and Vaccine Segment (2015)
AstraZeneca’s Approvals and Upcoming Drugs (2015)
Types of Influenza
Symptoms of Influenza
Supply Chain of Influenza Vaccine
Global Influenza Vaccine Market by Value (2012-2016)
Global Influenza Vaccine Market Forecast by Value (2017-2021)
Global Influenza Vaccine Production Capacity by Indication (2016)
Global Pandemic Influenza Vaccine Production Capacity (2012-2016)
Global Pandemic Influenza Vaccine Production Capacity Forecast (2017-2021)
Global Seasonal Influenza Vaccine Production Capacity (2012-2016)
Global Seasonal Influenza Vaccine Production Capacity Forecast (2017-2021)
Global Influenza Vaccine Market by Region (2016)
The US Influenza Vaccine Market by Value (2012-2016)
The US Influenza Vaccine Market Forecast by Value (2017-2021)
The US Influenza Vaccine Production Volume (2012-2016)
The US Influenza Vaccine Production Volume Forecast (2017-2021)
The US Influenza Vaccine Market Volume by Type (2016)
Japan’s Influenza Vaccine Market by Value (2012-2016)
Japan’s Influenza Vaccine Market Forecast by Value (2017-2021)
Germany’s Influenza Vaccine Market by Value (2012-2016)
Germany’s Influenza Vaccine Market Forecast by Value (2017-2021)
Vaccine Effectiveness for Influenza Seasons (2005-2016)
Global Spending on Medicines (2010-2020E)
Total Spending on Medicines in the US (2012-2016)
Global Healthcare Expenditure (2012-2016)
Global Ageing Population of 60 Years or Older (2000-2030E)
Global Influenza Vaccine Market Share (2016)
Revenue Comparison by Key Players (2016)
Market Cap Comparison by Key Players (2016)
The US Influenza Vaccine Production Volume Share (2016)
Novartis Revenue Share by Segments (2015)
Novartis AG’s Revenue and Net Income (2012-2015)
Sanofi S.A Net Sales Share by Business Segments (2015)
Sanofi S.A Net Sales and Net Income (2012-2015)
GlaxoSmithKline Plc. Net Sales Share by Segments (2015)
GlaxoSmithKline Plc. Net Sales and Operating Profit (2012-2015)
AstraZeneca Revenue by Segment (2015)
AstraZeneca’s Revenue (2012-2015)
List of Tables
Difference between Influenza Types A, B and C Viruses
Influenza Vaccine Side Effects
Flu Vaccines Lots Released by the FDA (2016/2017)
H1N1/H5N1 Vaccine in Development (2015-2016)
Number of Retail Clinics in the US (2015)
Global Influenza Vaccine Market Competition by Drugs & Indication (2016)
Sanofi S.A Key Product Enhancement Strategies (2015)
GlaxoSmithKline Plc. Core R&D Expenditure Allocation (2015)
GSK Product Development Pipeline in Pharmaceutical and Vaccine Segment (2015)
AstraZeneca’s Approvals and Upcoming Drugs (2015)
